EUVIMEDEUVIMED entdecken
Crossref

Antibody- and enzyme-free point-of-care detection of procalcitonin via synergistic nanomachines-activated catalytic assembly (SNCA) assay for early sepsis monitoring

Yuchen Guo, Xuelian Liu, Feiyue Wang, Sen Liang, Bo Pang, Jia Wei

Biosensors and Bioelectronics · 2027

DOI: 10.1016/j.bios.2026.119242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027. Verfasst von Yuchen Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, PR China. Hauptthemen laut MEDLINE: Procalcitonin, Biosensing Techniques, Sepsis. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Jilin University, Jilin Provincial Natural Science Foundation, Department of Science and Technology of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Procalcitonin (PCT) is an important biomarker for the early assessment and dynamic monitoring of sepsis. However, its routine measurement largely relies on centralized laboratory testing and protein-based recognition or signal-amplification components. Here, we developed an antibody- and enzyme-free synergistic nanomachines-activated catalytic assembly (SNCA) assay for rapid point-of-care detection of PCT. The assay integrates two functionally coupled nanomachines. The NanoTransducer consists of gold nanoparticles functionalized with an aptamer-based recognition probe carrying a catalyst strand. In cooperation with a second aptamer probe, it converts PCT-mediated dual recognition into nanoconfinement-triggered strand release. The released strand subsequently initiates catalytic hairpin assembly on a NanoAmplifier-loaded conductive PAAM/PA/PDA hydrogel electrode, producing an amplified differential pulse voltammetric signal. The assay exhibited a linear response from 10-3 to 103 ng/mL, with a detection limit of 2.35 × 10-4 ng/mL, and showed good specificity against potential interferents. A disposable ready-to-use reaction cartridge and a miniaturized wireless electrochemical analyzer were further developed, enabling automated PCT measurement in 15 min. As the entire process operates without protein-based antibodies or enzymes, the reaction cartridges demonstrated good storage stability. Clinical evaluation showed excellent agreement between the SNCA assay and the central laboratory reference method, while point-of-care testing provided higher temporal resolution for tracking postoperative PCT dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProcalcitoninBiosensing TechniquesSepsisHumansPoint-of-Care SystemsLimit of DetectionGoldMetal NanoparticlesAptamers, NucleotideElectrochemical TechniquesCatalysisRapid Diagnostic Tests

Stichwörter der Autor:innen

DNA assemblyEnzyme-free assayHydrogel electrodeNanomachinePortable deviceProcalcitonin

Substanzen

ProcalcitoninGoldAptamers, Nucleotide

Autor:innen und Institutionen

  • Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, PR China.
  • School of Public Health, Jilin University, Changchun, 130021, PR China.
  • School of Public Health, Jilin University, Changchun, 130021, PR China. Electronic address: bopang1@jlu.edu.cn.
  • School of Public Health, Jilin University, Changchun, 130021, PR China; Department of Thyroid Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, PR China. Electronic addre…

Förderung

  • Jilin University
  • Jilin Provincial Natural Science Foundation
  • Department of Science and Technology of Jilin Province
  • The First Hospital of Jilin University
  • National Natural Science Foundation of China

Zitieren

APA

Guo, Y., Liu, X., Wang, F., Liang, S., Pang, B., & Wei, J. (2027). Antibody- and enzyme-free point-of-care detection of procalcitonin via synergistic nanomachines-activated catalytic assembly (SNCA) assay for early sepsis monitoring. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119242

Vancouver

Guo Y, Liu X, Wang F, Liang S, Pang B, Wei J. Antibody- and enzyme-free point-of-care detection of procalcitonin via synergistic nanomachines-activated catalytic assembly (SNCA) assay for early sepsis monitoring. Biosensors and Bioelectronics. 2027. doi:10.1016/j.bios.2026.119242

BibTeX
@article{Guo2027,
  author = {Guo, Yuchen and Liu, Xuelian and Wang, Feiyue and Liang, Sen and Pang, Bo and Wei, Jia},
  title = {Antibody- and enzyme-free point-of-care detection of procalcitonin via synergistic nanomachines-activated catalytic assembly (SNCA) assay for early sepsis monitoring},
  journal = {Biosensors and Bioelectronics},
  year = {2027},
  doi = {10.1016/j.bios.2026.119242}
}
Kostenlos starten →